SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 70, Issue 6, 2011, Pages 961-967

  Hanly, J G ^a   Urowitz, M B ^b   Jackson, D ^c   Bae, S C ^d   Gordon, C ^e   Wallace, D J ^f   Clarke, A ^g   Bernatsky, S ^g   Vasudevan, A ^h   Isenberg, D ⁱ   Rahman, A ⁱ   Sanchez Guerrero, J ^j   Romero Diaz, J ^j   Merrill, J T ^k   Fortin, P R ^b   Gladman, D D ^b   Bruce, I N ^l   Steinsson, K ^m   Khamashta, M ⁿ   Alarcon G S ^o   Fessler, B ^o   Petri, M ^p   Manzi, S ^q   Nived, O ^r   Sturfelt, G ^r   Ramsey Goldman, R ^s   Dooley, M A ^t   Aranow, C ^u   Van Vollenhoven, R ^v   Ramos Casals, M ^w,x   Zoma, A ^y   Kalunian, K ^w   Farewell, V ^c   more..

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

^d Hanyang Institute of Bioscience and Biotechnology   (South Korea)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MONTREAL GENERAL HOSPITAL   (Canada)

^h Downstate Health Sciences University   (United States)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^k OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^l UNIVERSITY OF MANCHESTER   (United Kingdom)

^m LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

ⁿ KING'S COLLEGE LONDON   (United Kingdom)

^o and Clinical Center   (United States)

^p JOHNS HOPKINS UNIVERSITY   (United States)

^q UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^r LUND UNIVERSITY HOSPITAL   (Sweden)

^s NORTHWESTERN UNIVERSITY   (United States)

^t UNIVERSITY OF NORTH CAROLINA   (United States)

^u New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^v KAROLINSKA INSTITUTE   (Sweden)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x HOSPITAL CLÍNIC   (Spain)

^y HAIRMYRES HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CONFUSION; ADULT; AGE; ANXIETY DISORDER; ARTICLE; ASEPTIC MENINGITIS; AUTONOMIC DYSFUNCTION; BRAIN DISEASE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; CRANIAL NEUROPATHY; DEMYELINATING DISEASE; DISEASE ACTIVITY; DISEASE DURATION; EDUCATION; ETHNICITY; FEMALE; GENDER; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL COMPONENT SUMMARY SCORE; MENTAL DETERIORATION; MENTAL DISEASE; MENTAL HEALTH; MONONEUROPATHY; MOOD DISORDER; MOTOR DYSFUNCTION; MYASTHENIA GRAVIS; OUTCOME ASSESSMENT; PHYSICAL CAPACITY; PLEXOPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; QUALITY OF LIFE; RELIABILITY; SCORING SYSTEM; SEIZURE; SENSITIVITY ANALYSIS; SHORT FORM 36; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MENTAL DISORDERS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SCHOOLS, PUBLIC HEALTH; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955863506     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.138792     Document Type: Article

References (30)

1. Ainiala H, Loukkola J, Peltola J, et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001 ; 57 : 496-500. (Pubitemid 32757599) (Pubitemid 32757599)
2. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002 ; 58 : 1214-20. (Pubitemid 34411865) (Pubitemid 34411865)
3. Hanly JG, McCurdy G, Fougere L, et al. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004 ; 31 : 2156-62. (Pubitemid 39453234) (Pubitemid 39453234)
4. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003 ; 30 : 985-92. (Pubitemid 36529618) (Pubitemid 36529618)
5. Sibbitt WL Jr, Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002 ; 29 : 1536-42. (Pubitemid 34755624) (Pubitemid 34755624)
6. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999 ; 42 : 599-608.
7. Hanly JG, Su L, Farewell V, et al. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 2009 ; 36 : 1449-59.
8. Hanly JG, Urowitz MB, Sanchez-Guerrero J, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007 ; 56 : 265-73. (Pubitemid 46106200) (Pubitemid 46106200)
9. Hanly JG, Urowitz MB, Siannis F, et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 2008 ; 58 : 843-53. (Pubitemid 351364883) (Pubitemid 351364883)
10. Hanly JG, Urowitz MB, Su L, et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum 2008 ; 59 : 721-9. (Pubitemid 351679549) (Pubitemid 351679549)
11. Hanly JG, Urowitz MB, Su L, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010 ; 69 : 529-35.
12. Isenberg D, Ramsey-Goldman R. Systemic Lupus International Collaborating Group - onwards and upwards? Lupus 2006 ; 15 : 606-7. (Pubitemid 44661749) (Pubitemid 44661749)
13. Hochberg M C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 ; 40 : 1725.
14. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992 ; 35 : 630-40.
15. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996 ; 39 : 363-9. (Pubitemid 26085211) (Pubitemid 26085211)
16. Thumboo J, Fong KY, Ng TP, et al. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol 1999 ; 26 : 97-102. (Pubitemid 29051403) (Pubitemid 29051403)
17. Brazier J, Usherwood T, Harper R, et al. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 1998 ; 51 : 1115-28. (Pubitemid 28527167) (Pubitemid 28527167)
18. Ainiala H, Hietaharju A, Loukkola J, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001 ; 45 : 419-23. (Pubitemid 32979846) (Pubitemid 32979846)
19. Thumboo J, Fong KY, Chan SP, et al. A prospective study of factors affecting quality of life in systemic lupus erythematosus. J Rheumatol 2000 ; 27 : 1414-20. (Pubitemid 30354037) (Pubitemid 30354037)
20. Strand V, Crawford B, Singh J, et al. Use of 'spydergrams' to present and interpret SF-36 health-related quality of life data across rheumatic diseases. Ann Rheum Dis 2009 ; 68 : 1800-4.
21. Mok CC, Lau CS, Wong RW. Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study. Am J Med 2003 ; 115 : 59-62. (Pubitemid 36831123) (Pubitemid 36831123)
22. Tokunaga M, Saito K, Kawabata D, et al. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis 2007 ; 66 : 470-5. (Pubitemid 46580466) (Pubitemid 46580466)
23. Denburg SD, Carbotte RM, Denburg JA. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum 1994 ; 37 : 1311-20. (Pubitemid 24320748) (Pubitemid 24320748)
24. Harrison MJ, Morris KA, Horton R, et al. Results of intervention for lupus patients with self-perceived cognitive difficulties. Neurology 2005 ; 65 : 1325-7. (Pubitemid 41508241) (Pubitemid 41508241)
25. Steens SC, Bosma GP, ten Cate R, et al. A neuroimaging follow up study of a patient with juvenile central nervous system systemic lupus erythematosus. Ann Rheum Dis 2003 ; 62 : 583-6. (Pubitemid 36606296) (Pubitemid 36606296)
26. Leung FK, Fortin PR. Intravenous cyclophosphamide and high dose corticosteroids improve MRI lesions in demyelinating syndrome in systemic lupus erythematosus. J Rheumatol 2003 ; 30 : 1871-3. (Pubitemid 36962470) (Pubitemid 36962470)
27. Barile-Fabris L, Ariza-Andraca R, Olguín-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 2005 ; 64 : 620-5. (Pubitemid 40469095) (Pubitemid 40469095)
28. Neuwelt CM, Lacks S, Kaye BR, et al. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 1995 ; 98 : 32-41.
29. Tam LS, Wong A, Mok VC, et al. The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus. J Rheumatol 2008 ; 35 : 1038-45. (Pubitemid 351813149) (Pubitemid 351813149)
30. Strand V, Crawford B. Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies. Expert Rev Pharmacoecon Outcomes Res 2005 ; 5 : 317-26. (Pubitemid 40894969) (Pubitemid 40894969)